-
公开(公告)号:US07153846B2
公开(公告)日:2006-12-26
申请号:US10971228
申请日:2004-10-22
IPC分类号: C07D223/12 , A61K31/55 , A61P35/00
CPC分类号: C12R1/01 , C07D223/12 , C12P17/10
摘要: The present invention relates to bengamide derivatives which are formed, during fermentation, by the microorganism Myxococcus virescens ST200611 (DSM 15898), to their use for treating cancer diseases, to pharmaceuticals which comprise bengamide derivatives, to a process for preparing bengamides of the formula (V) and to the microorganism Myxococcus virescens ST200611 (DSM 15898)
摘要翻译: 本发明涉及在发酵期间由微生物粘球菌ST200611(DSM15898)在治疗癌症疾病中用于治疗癌症疾病的孟加拉酰胺衍生物,涉及制备式(b)的班格酰胺的方法, V)和微生物粘液菌(Myxococcus virescens)ST200611(DSM 15898)
-
公开(公告)号:US07534591B2
公开(公告)日:2009-05-19
申请号:US11555804
申请日:2006-11-02
CPC分类号: C12R1/01 , C07D223/12 , C12P17/10
摘要: The present invention relates to bengamide derivatives which are formed, during fermentation, by the microorganism Myxococcus virescens ST200611 (DSM 15898), to their use for treating cancer diseases, to pharmaceuticals which comprise bengamide derivatives, to a process for preparing bengamides of the formula (V) and to the microorganism Myxococcus virescens ST200611 (DSM 15898).
-
公开(公告)号:US20050171089A1
公开(公告)日:2005-08-04
申请号:US10971228
申请日:2004-10-22
IPC分类号: C07D223/12 , C12P17/10 , A61K31/55
CPC分类号: C12R1/01 , C07D223/12 , C12P17/10
摘要: The present invention relates to bengamide derivatives which are formed, during fermentation, by the microorganism Myxococcus virescens ST200611 (DSM 15898), to their use for treating cancer diseases, to pharmaceuticals which comprise bengamide derivatives, to a process for preparing bengamides of the formula (V) and to the microorganism Myxococcus virescens ST200611 (DSM 15898).
摘要翻译: 本发明涉及在发酵期间由微生物粘球菌ST200611(DSM15898)在治疗癌症疾病中用于治疗癌症疾病的孟加拉酰胺衍生物,涉及制备式(b)的班格酰胺的方法, V)和微生物粘液菌(Myxococcus virescens)ST200611(DSM 15898)。
-
4.
公开(公告)号:US20070065932A1
公开(公告)日:2007-03-22
申请号:US11555809
申请日:2006-11-02
IPC分类号: C12N1/20
CPC分类号: C12R1/01 , C07D223/12 , C12P17/10
摘要: The present invention relates to bengamide derivatives which are formed, during fermentation, by the microorganism Myxococcus virescens ST200611 (DSM 15898), to their use for treating cancer diseases, to pharmaceuticals which comprise bengamide derivatives, to a process for preparing bengamides of the formula (V) and to the microorganism Myxococcus virescens ST200611 (DSM 15898).
摘要翻译: 本发明涉及在发酵期间由微生物粘球菌ST200611(DSM15898)在治疗癌症疾病中用于治疗癌症疾病的孟加拉酰胺衍生物,涉及制备式(b)的班格酰胺的方法, V)和微生物粘液菌(Myxococcus virescens)ST200611(DSM 15898)。
-
-
-